Scott Canute, Director at Flexion Therapeutics, holds 0.00 shares in Immunomedics (Ticker: IMMU), holds 4.50K shares in Flexion Therapeutics (Ticker: FLXN), holds 13.70K shares in Akebia Therapeutics (Ticker: AKBA).
Scott Canute latest transaction was an Uninformative Sell of ―.
What was Scott Canute's most profitable transaction?
Scott Canute’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Scott Canute's role in Flexion Therapeutics?
Scott Canute's role in Flexion Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.